Delivery Order SPE2DB25D3022-SPE2DB25FWBXM

Award Date 7/10/25
Potential Completion Date 7/11/25
Potential Value $13K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is a delivery order valued at $39,633.37. The contract is for the supply of AVONEX PEN 30 MCG/0.5 ML (4PK)S, a pharmaceutical product, to the Defense Logistics Agency (DLA), a defense agency. The contract is not set aside and is a firm fixed-price contract with a completion date of June 11, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $47,700.47 firm fixed price contract is for the supply of AVONEX PEN 30 MCG/0.5 ML (4PK)S, a specialty pharmaceutical product. The contract has an ultimate completion date of April 14, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,259.84 firm-fixed-price contract is for the supply of AVONEX PEN 30 MCG/0.5 ML (4PK)S, a specialty medication, to support military healthcare programs. The contract has an ultimate completion date of March 27, 2025. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $59,107.39 firm fixed price delivery order is for the supply of AVONEX PEN 30 MCG/0.5 ML (4PK)S, a pharmaceutical product. The contract has a period of performance through May 7, 2025 and does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $20,254.38, is for the supply of AVONEX PEN 30 MCG/0.5 ML KITS, a pharmaceutical product. The contract is a firm fixed-price delivery order with an ultimate completion date of October 30, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of AVONEX PEN 30 MCG/0.5 ML KITS. The $81,375.87 firm fixed-price delivery order was issued by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of December 6, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,758.66 firm fixed-price contract is for the delivery of AVONEX PEN 30 MCG/0.5 ML (4PK)S, a pharmaceutical product. The contract has an ultimate completion date of June 10, 2025 and is not a set-aside contract, indicating open competition. Amerisourcebergen Drug Corp is the prime contractor and this...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,991.96 firm fixed-price delivery order is for the supply of AVONEX PEN 30 MCG/0.5 ML KITS, a specialty medication. The contract has an ultimate completion date of September 25, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of AVONEX PEN 30 MCG/0.5 ML KITS. The contract has a ceiling value of $20,931.26 and a period of performance through October 7, 2024. It is a firm fixed-price delivery order contract, without any set-aside designation. AmerisourceBergen, through its corporate office division, is a primary vendor for providing a wide range of...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,345.67, is for the delivery of AVONEX PEN 30 MCG/0.5 ML KITS, a specialty medication. The contract has an ultimate completion date of January 13, 2025 and is a Firm Fixed Price Delivery Order. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery...
  • SPE2DB25D3022
    Indefinite Delivery Contract
  • SPE2DB25D3022-SPE2DB25FWBXM
    Delivery Order

This is a delivery order federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The $12,933.14 firm-fixed-price contract is for the delivery of AVONEX PEN 30 MCG/0.5 ML (4PK)S, a pharmaceutical product. The contract has an ultimate completion date of July 11, 2025. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This prime contract allows for multiple delivery orders across different therapeutic categories, positioning AmerisourceBergen as a critical vendor in supporting federal medical procurement needs, particularly for military and veteran healthcare systems. The contract award is not designated as a set-aside.

Generated 10/12/25, 1:20 AM